QT Imaging (NASDAQ:QTI) Rating Increased to Hold at Wall Street Zen

Wall Street Zen upgraded shares of QT Imaging (NASDAQ:QTI) to a hold rating in a report published on Saturday.

A number of other brokerages also recently issued reports on QTI. Lake Street Capital initiated coverage on QT Imaging in a research report on Friday, January 30th. They set a “buy” rating on the stock. Zacks Research raised QT Imaging from a “strong sell” rating to a “hold” rating in a research report on Monday, April 20th. Finally, Weiss Ratings started coverage on QT Imaging in a research note on Thursday, January 29th. They set a “sell (e+)” rating for the company. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, QT Imaging presently has an average rating of “Hold”.

QT Imaging Trading Down 18.8%

Shares of NASDAQ:QTI opened at $5.45 on Friday. The company has a market capitalization of $65.62 million, a P/E ratio of -4.39 and a beta of 0.01. QT Imaging has a 1 year low of $0.65 and a 1 year high of $8.50. The company has a debt-to-equity ratio of 1.38, a current ratio of 2.49 and a quick ratio of 2.17. The business’s 50 day simple moving average is $6.59 and its 200 day simple moving average is $6.19.

QT Imaging (NASDAQ:QTI) last issued its quarterly earnings results on Wednesday, May 13th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.11). The company had revenue of $6.53 million for the quarter, compared to analyst estimates of $6.45 million. QT Imaging had a negative return on equity of 4,220.38% and a negative net margin of 58.93%. On average, research analysts anticipate that QT Imaging will post -0.18 EPS for the current fiscal year.

About QT Imaging

QT Imaging Ltd. (NASDAQ: QTI) is a medical technology company specializing in the development and commercialization of advanced ultrasound imaging solutions. The company focuses on real-time volumetric imaging systems designed to enhance diagnostic capabilities in obstetrics, gynecology and other clinical applications. QT Imaging’s flagship Q.VIEW® system and associated software suite enable practitioners to capture, analyze and visualize high-resolution 3D/4D ultrasound images, offering improved workflow efficiency and enhanced patient care.

QT Imaging’s product portfolio includes proprietary transducers, imaging consoles and software platforms that can be integrated with existing ultrasound scanners from leading original equipment manufacturers.